Connor, Clark & Lunn Investment Management Ltd. - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 4.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$11,000
+10.0%
18,5000.0%0.00%
Q4 2016$10,000
-37.5%
18,5000.0%0.00%
Q3 2016$16,000
-11.1%
18,5000.0%0.00%
Q2 2016$18,000
+5.9%
18,5000.0%0.00%
Q1 2016$17,000
-60.5%
18,500
-46.1%
0.00%
Q4 2015$43,000
+72.0%
34,300
+69.0%
0.00%
Q3 2015$25,000
-55.4%
20,300
-36.6%
0.00%
-100.0%
Q2 2015$56,000
-46.2%
32,000
-55.3%
0.00%0.0%
Q1 2015$104,000
+126.1%
71,600
+30.4%
0.00%
Q4 2014$46,000
-24.6%
54,9000.0%0.00%
Q3 2014$61,000
-43.0%
54,9000.0%0.00%
-100.0%
Q2 2014$107,000
+15.1%
54,900
-2.3%
0.00%0.0%
Q1 2014$93,00056,2000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
NEA Management Company, LLC 20,896,038$17,135,0000.89%
X-Square Capital, LLC 270,680$222,0000.15%
New Leaf Venture Partners, L.L.C. 402,118$330,0000.09%
GSA CAPITAL PARTNERS LLP 688,431$565,0000.06%
EXCALIBUR MANAGEMENT CORP 51,000$42,0000.04%
WealthTrust Axiom LLC 138,505$113,0000.04%
Caption Management, LLC 855,200$701,0000.04%
Evercore Wealth Management, LLC 418,414$343,0000.01%
Gemmer Asset Management LLC 1,939$32,0000.01%
Ausdal Financial Partners, Inc. 23,000$19,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders